Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Lftd Partners (LIFD) Cash & Equivalents (2016 - 2025)

Lftd Partners has reported Cash & Equivalents over the past 13 years, most recently at $1.8 million for Q4 2025.

  • Quarterly Cash & Equivalents fell 17.69% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, down 17.69% year-over-year, with the annual reading at $1.8 million for FY2025, 17.69% down from the prior year.
  • Cash & Equivalents was $1.8 million for Q4 2025 at Lftd Partners, down from $1.9 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $4.6 million in Q2 2024 and troughed at $830091.0 in Q1 2021.
  • The 5-year median for Cash & Equivalents is $3.3 million (2023), against an average of $3.1 million.
  • The largest YoY upside for Cash & Equivalents was 2646.49% in 2021 against a maximum downside of 77.86% in 2021.
  • A 5-year view of Cash & Equivalents shows it stood at $1.6 million in 2021, then surged by 120.29% to $3.5 million in 2022, then rose by 23.42% to $4.4 million in 2023, then plummeted by 50.73% to $2.1 million in 2024, then dropped by 17.69% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for LIFD's Cash & Equivalents are $1.8 million (Q4 2025), $1.9 million (Q3 2025), and $2.1 million (Q2 2025).